RECURSION PHARMACEUTICALS INC. - CLASS A COMMON S

Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results

08 8月 2023 07:58:00 条件 Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conference

01 8月 2023 08:30:00 条件 Nasdaq GlobeNewswire

Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

26 7月 2023 18:58:00 条件 Nasdaq GlobeNewswire

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

12 7月 2023 08:30:00 条件 Nasdaq GlobeNewswire

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

26 6月 2023 11:48:04 条件 Nasdaq GlobeNewswire

Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

13 6月 2023 08:00:01 条件 Nasdaq GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

01 6月 2023 08:30:00 条件 Nasdaq GlobeNewswire

Altitude Lab Relocates to Gateway’s BioHive Hub

25 5月 2023 16:00:00 条件 Nasdaq GlobeNewswire

Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results

08 5月 2023 08:14:39 条件 Nasdaq GlobeNewswire

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

08 5月 2023 07:59:00 条件 Nasdaq GlobeNewswire